🔥Telegram İfşa

From preterm birth risks to lung cancer outcomes, RWD is changing what we know about patient care. Panalgo’s Mike Munsell, PHD, spoke with Drug Discovery & Development about two new studies presented at ICPE: vist.ly/4avsj Explore the findings at the link in this post.

Breaking down international data barriers has been a long-standing challenge for life sciences companies. In this blog post, ErikMaul, Senior Director of RWE Partnerships at Panalgo, shares how IHD Cloud is changing the game. vist.ly/4a2ut

Data + analytics + AI = powerful. But sometimes you need expert support. That’s where our PhD-level health economists and data scientists come in. Let’s explore how our team can accelerate your evidence generation at #ISPOREurope. Meet us in Glasgow: vist.ly/4bc46

GenAI isn’t just speeding things up in pharma—it’s changing how teams work. In Biopharma Dive, Niyati Parikh explores how GenAI is helping life sciences organizations make insights more transparent, accessible, and actionable across teams. vist.ly/4beav

As the IRA reshapes Medicare drug pricing, one big question remains: Are we making healthcare more equitable—or just less expensive? In HealthEconomics.com, Mike Munsell explores how real-world data can help answer that question. Read the article: vist.ly/4biqv

📘 Booklet Download: Discover how top pharma, med device & research teams use real-world evidence to drive real-world impact with Panalgo. Explore eight case studies that show how they accelerate insights, prove value, and transform research. Download now: vist.ly/4bqfh

GenAI is transforming pharma from the inside out. It’s not only about faster processes—it’s about smarter, more connected teams. In Biopharma Dive, Niyati Parikh reveals how it’s unlocking actionable insights across the organization. vist.ly/4bv8r

Accessing real-world data across international borders has long been a headache, but Panalgo’s IHD Cloud is changing the game. vist.ly/4bzgi Erik Maul, Senior Director of RWE Partnerships at Panalgo, explains how. Check out the article at the link in this post.

Our team is excited to showcase new cutting-edge research at #ISPOREurope. With NorstellaLinQ real-world data and the IHD platform, they uncovered valuable insights on resource use and cost for recurrent respiratory papillomatosis. Don’t miss it > vist.ly/4c5rj

Can COVID-19 during pregnancy impact delivery outcomes? Panalgo’s Mike Munsell, PHD, shares how our mother-infant linked data uncovers real-world insights into maternal and child health. Read the full story in Drug Discovery & Development: vist.ly/4c9wz

From preterm birth risks to lung cancer outcomes, RWD is changing what we know about patient care. Panalgo’s Mike Munsell, PHD, spoke with Drug Discovery & Development about two new studies presented at ICPE: vist.ly/4cebx Explore the findings at the link in this post.

Lower costs don’t always mean better access. vist.ly/4cjru In @HealthEconomicscom, @MikeMunsell writes about how real-world data helps uncover how the Inflation Reduction Act is shaping patient outcomes and equity across populations. Read the article for more.

Define cohorts. Select datasets. Generate regulatory-grade evidence. It all starts with one question. Meet Ella: vist.ly/4cnkm

We spoke with Erik Maul, Senior Director of RWE Partnerships at Panalgo, to learn how IHD Cloud enables companies to access international data silos without physically moving data, thereby accelerating insights and reducing costs. vist.ly/4ctkq